Foreign nationals now eligible for Covid vaccination in India: Govt

To ensure safety from Covid-19, the Union Health Ministry has taken a decision to allow foreign nationals residing in India to register on CoWin portal and get vaccinated against the disease

covaxin, bharat biotech, coronavirus vaccine, covid-19, vaccination
Press Trust of India New Delhi
2 min read Last Updated : Aug 09 2021 | 8:08 PM IST

To ensure safety from COVID-19, the Union Health Ministry has taken a decision to allow foreign nationals residing in India to register on CoWin portal and get vaccinated against the disease.

They can use their passport as identity document for the purpose of registration on CoWIN portal, the health ministry said in a statement.

Once they are registered on this portal, they will get a slot for vaccination.

According to the statement, a significant number of foreign nationals are living in India, especially in large metropolitan areas. In these areas, the potential of spread of COVID-19 is high due to higher population density. To counter any possibility of such occurrence, it is important to vaccinate all eligible persons.

"In a landmark initiative to ensure safety from COVID-19, the Ministry of Health has taken a decision to allow foreign nationals residing in India to get registered on CoWin portal to take COVID-19 vaccine.

"This initiative will ensure the safety of foreign nationals residing in India. It will also bring down the possibilities of further transfer of infection from unvaccinated persons residing in India. It will also ensure overall safety from further transmission of coronavirus," the ministry said in the statement.

The national COVID-19 vaccination programme is being implemented across all states and union territories since January 16, 2021.

The vaccination programme in its current phase covers all citizens aged 18 years and above. As on August 9, 2021, India has administered more than 51 crore vaccine doses across the country.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineVaccination

First Published: Aug 09 2021 | 8:08 PM IST

Next Story